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Abstract
Background: Six asthma candidate genes, ADAM33, NPSR1, PHF11, DPP10, HLA-G, and CYFIP2,
located at different chromosome regions have been positionally cloned following the reported
linkage studies. For ADAM33, NPSR1, and CYFIP2, the associations with asthma or asthma-related
phenotypes have been studied in East Asian populations such as Chinese and Japanese. However,
for PHF11, DPP10, and HLA-G, none of the association studies have been conducted in Asian
populations. Therefore, the aim of the present study is to test the associations between these three
positionally cloned genes and asthma or asthma-related phenotypes in a Chinese population.
Methods: Two, five, and two single nucleotide polymorphisms (SNPs) in the identified top regions
of PHF11, DPP10, and HLA-G, respectively, were genotyped in 1183 independent samples. The
study samples were selected based on asthma affectation status and extreme values in at least one
of the following three asthma-related phenotypes: total serum immunoglobulin E levels, bronchial
responsiveness test, and skin prick test. Both single SNP and haplotype analyses were performed.
Results: We found that DPP10 was significantly associated with bronchial hyperresponsiveness
(BHR) and BHR asthma after the adjustment for multiple testing; while the associations of PHF11
with positive skin reactions to antigens and the associations of HLA-G with BHR asthma were only
nominally significant.
Conclusion: Our study is the first one to provide additional evidence that supports the roles of
DPP10 in influencing asthma or BHR in a Chinese population.
Background
Six genes, plant homeodomain finger protein 11
(PHF11), dipeptidyl-peptidase 10 (DPP10), histocompat-
ibility antigen, class I, G (HLA-G), ADAM metallopepti-
dase domain 33 (ADAM33), neuropeptide S receptor 1
(NPSR1, previously GPR154 or GPRA), and cytoplasmic
FMR1 interacting protein 2 (CYFIP2), have been identi-
fied to be associated with asthma and asthma-related phe-
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notypes following linkage studies [1-6]. These genes span
a wide range of functions, which were either unknown or
would not have been considered to be implicated in the
etiology of asthma before their discovery.
PHF11 was positionally cloned by Zhang et al. [1] and has
been found to be associated with IgE levels, severe clinical
asthma and childhood atopic dermatitis in Caucasian
populations [1,7]. A more recent study demonstrated that
knockdown of PHF11 expression reduced expression of
the T(H)1 - type cytokines IFN-gamma and IL-2 [8]. Allen
et al. identified DPP10 and showed its associations with
asthma in Caucasian populations [2]. Other studies have
demonstrated that DPP10 modulated functional proper-
ties of Kv4-mediated A-type K+ channels in the central
neurons via its intracellular and transmembrane domains
[9-11]. Nicolae et al. positionally cloned HLA-G and
showed that HLA-G was associated with asthma, bron-
chial hyperresponsiveness (BHR) and atopy in Caucasian
populations [3]. HLA-G was expressed in bronchial epi-
thelial cells [3] and may be involved in airway remodeling
by inhibiting angiogenesis [12]. ADAM33 was identified
by Van Eerdewegh et al. [4], and following functional
studies have suggested that it might play roles in airway
remodeling by promoting angiogenesis [13]. Laitinen et
al. identified NPSR1 as an asthma candidate gene and
reported that levels of the NPSR1-B isoform were
increased in airway smooth muscle cells and epithelial
cells in asthma patients compared to healthy controls,
and NPSR1 was up-regulated in a mouse model of ovalbu-
min-induced inflammation [5]. CYFIP2 was positionally
cloned by Noguchi et al. [6] and has been implicated in
Rac-1-mediated T cell adhesion [14].
Recently, in studies of childhood asthma, Hersh et al.
attempted to replicate associations with five positionally
cloned asthma susceptibility genes, including ADAM33,
DPP10, NPSR1, HLA-G, and PHF11, using both Cauca-
sian and Hispanic families [15]. However, the replication
with asthma was only found in NPSR1 and PHF11 in both
cohorts, yet for NPSR1, the opposite alleles of SNPs were
associated in either cohort, and for PHF11, there was no
overlap in the associated SNPs across the two cohorts; no
association was found in ADAM33, DPP10 or HLA-G in
either cohort. A more recent study was conducted to rep-
licate associations of 93 previously reported asthma can-
didate genes, including the six positionally cloned genes,
with asthma and asthma-related phenotypes using 5,565
individuals (predominantly Caucasian); however, no sig-
nificant associations were found for these six genes [16].
Actually, the associations of ADAM33, NPSR1, and
CYFIP2 with asthma or asthma-related phenotypes have
been studied in Chinese or Japanese populations
[6,17,18]. However, to our knowledge, there is no further
confirmation study conducted for DPP10, HLA-G, and
PHF11, and the reported associations in non-Caucasian
populations have yet to be examined. In this article, we
examined the associations of polymorphisms in the iden-
tified top regions of PHF11, DPP10, and HLA-G with
asthma and asthma-related phenotypes in a Chinese pop-
ulation, using a population-based study design.
Methods
Study Population and Phenotype Definition
In the current study, based on asthma affectation status
and extreme values in asthma-related phenotypes, we
selected a total of 1183 samples from 3022 families (2752
asthma index families and 270 reference families) that
were enrolled from Anqing city in China. A detailed
description of study site, subject recruitment, and pheno-
type measurements has been presented elsewhere previ-
ously [19,20]. In brief, 2752 index families, which
included both parents and at least 2 offspring who were
≥8 years old and had physician-diagnosed asthma, were
enrolled. In addition, 270 reference families were ran-
domly selected from the same area. The following data
were collected from each participant: 1) a questionnaire
to assess respiratory symptoms, history of disease, smok-
ing and alcohol consumption, and occupational and envi-
ronmental exposure; 2) a standardized spirometry test to
measure forced expiratory volume in 1s (FEV1) and forced
vital capacity (FVC); 3) airway methacholine (MTCH)
challenge test with the following 5 combinations of
number of breaths and methacholine concentration in
sequential order: 1 breath of 1 mg/mL, 1 breath of 5 mg/
mL, 4 breaths of 5 mg/mL, 1 breath of 25 mg/mL, and 4
breaths of 25 mg/mL; the test was terminated at the dose
that produced a ≥20% drop in FEV1 from the baseline
(PD20), or at the final dose if PD20 was not observed;
BHR was defined as a PD20 was observed during the test;
and BHR asthma was defined as physician-diagnosed
asthma combined with BHR; 4) skin prick test with fol-
lowing antigens applied: cockroach, house dust, mixed
trees, mixed grasses, tobacco leaf, polyvalent molds, mite
(Dermatophagoides farinae), artemisia, silk, and mite (Der-
matophagoides pteronyssinus); an histamine (0.5%) and a
saline control were also applied; an antigen-induced
wheal size >2 mm of the saline control value was consid-
ered positive; a positive skin test was defined as at least
one positive reaction to the applied antigens was
observed; and 5) measurement of serum IgE levels.
The 1183 samples in this study were in two groups based
on their phenotypes. The subjects in the first group (n =
543) had physician-diagnosed asthma and one or more of
the following conditions: 1) an observed PD20 at or
before the third dose in the MTCH challenge test; 2) total
serum IgE in the top quartile of the population IgE distri-
bution; and 3) total number of positive reactions to the 10
allergens in the skin prick test in the top quartile of theBMC Medical Genetics 2009, 10:123 http://www.biomedcentral.com/1471-2350/10/123
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population distribution. The subjects in the second group
(n = 640) did not have physician diagnosed asthma and
met one or more of the following conditions: 1) PD20 not
observed during the MTCH challenge test; 2) total serum
IgE in the bottom quartile of the population IgE distribu-
tion; and 3) total number of positive reactions to the 10
allergens in the bottom quartile of the population distri-
bution. The 1183 samples were unrelated with each other.
The Human Subjects Committees at both the Harvard
School of Public Health and the Anhui Medical University
approved the study. Written informed consent was
explained to, read and signed by each participant.
SNP Selection and Genotyping
DNA was extracted from leukocytes in peripheral blood
using standard techniques. The aim of the current study
was to replicate the previously identified associations.
Therefore, for PHF11 we selected two SNPs (rs2247119
and rs1046295) that produced the strongest association
in the previous report [7]. The previous association in
DPP10 peaked at a microsatellite marker D2S308 in the
initial exons [2]. Instead of relying on the microsatellite
markers, we selected five tag SNPs (rs10192393,
rs1430092, rs1430090, rs6737251, and rs7580359) that
tagged a 50-kb region flanking the initial exons of DPP10.
SNP rs1632947 in the promoter region of HLA-G pro-
duced the strongest association in the previous report [3].
However this SNP was not genotyped in the HapMap
project. Instead, we selected two tag SNPs (rs2247119 and
rs1046295) that tagged the whole 3-kb promoter region
of HLA-G. All the tagging selections were done using the
HapMap Chinese (CHB) genotype data [21] and the
SNPbrowser (Applied Biosystems, Foster City, CA), and
tagged all the SNPs with ≥5% minor allele frequency
(MAF) in the region of interest with a minimal pairwise r2
of 0.8. Genotyping was done using Taqman genotyping
assays designed and manufactured by Applied Biosys-
tems. The genotype call rate of the 9 selected SNPs ranged
from 95.0% to 98.8%. A random 5% of the samples were
independently repeated to confirm the genotyping results.
The concordance of these duplicated samples was 100%.
Statistical Analyses
In our association analyses, we examined the associations
of polymorphisms in the three genes to asthma and
asthma-related phenotypes according to previous study
results [1-3,7,9-11], i.e. total IgE levels and skin prick test
for PHF11, and MTCH challenge test for DPP10 and HLA-
G. Among these phenotypes, the log10 transformed IgE
was quantitative; asthma status, MTCH challenge test
results (BHR), and skin prick test results were treated as
dichotomous. Since it has been shown that combining
asthma-related phenotypes with physician's diagnosis of
asthma led to a stronger association to the asthma candi-
date genes [4,22], in the current study, dichotomous
asthma-related phenotypes with a single trait p value less
than 0.1 were further combined with asthma status to cre-
ate more extreme and genetically homogeneous cases and
controls, so that all cases were asthmatic with the positive
asthma-related phenotype, while all controls were non-
asthmatic with the negative asthma-related phenotype.
We used a t test and a χ2 test to test for differences in dis-
tributions of quantitative traits and categorical variables
between asthmatic and non-asthmatic samples, respec-
tively. The same methods were used to test for differences
in distributions of those variables among different geno-
types as well. We examined each SNP for Hardy-Weinberg
equilibrium (HWE) in non-asthmatic samples using a χ2
test. We used Haploview [23] to calculate LD between the
SNPs among the same gene and to infer haplotype blocks.
We performed single-SNP association tests on asthma and
asthma-related phenotypes using logistic regression or
linear regression analyses under different genetic models
(additive or dominant) with the adjustment for age, gen-
der, height, weight, BMI and smoking status. We also per-
formed haplotype association tests using Haplo.Stats
[24]. All the analyses were performed by using the statisti-
cal software program R http://www.r-project.org. To
account for the multiple tests we made with various SNPs,
haplotypes and phenotypes in the study, a permutation-
based procedure was used to estimate empirical study-
wide type I error rate of 0.05 [25]. In brief, genotypes of
all SNPs were randomly permuted 10000 times. After
each permutation, same single-SNP and haplotype analy-
ses with multiple phenotypes were performed and the
minimum p value among these tests was recorded. As a
result, 10000 minimum p values were created to represent
their null distribution. The study-wide type I error rate of
0.05 was then estimated as the 500th (10000 × 0.05)
smallest minimum p value.
Results
9 SNPs across the top hit regions in PHF11, DPP10, and
HLA-G were selected to replicate the previously identified
associations. We tested these SNPs for association in 1183
unrelated subjects selected from our study population.
The phenotypic characteristics of the study samples are
summarized in Table 1. There were only slight differences
between asthmatic and non-asthmatic samples in terms of
age, height, weight and BMI. All SNPs were in HWE, and
their MAFs are listed in Table 2.
PHF11 In our analyses, the rs2247119 C allele tended to
increase the risk of positive skin reactions to antigens,
although it was not statistically significant (Table 3).
However, compared to the TG haplotype constructed by
rs2247119 and rs1046295, the CG haplotype was nomi-
nally associated with a 2.05 times higher risk of skin reac-
tions to antigens (nominal P = 0.023) (Table 4). FurtherBMC Medical Genetics 2009, 10:123 http://www.biomedcentral.com/1471-2350/10/123
Page 4 of 9
(page number not for citation purposes)
combining skin reactions and asthma status did not yield
more significant association results (Table 3 and 4). After
the adjustment for multiple testing, the study-wide signif-
icance level was estimated as 0.0041 by the permutation
procedure. Compared to this level, the haplotype associa-
tion was not significant.
DPP10 Among the five studied SNPs, rs10192393 pro-
duced the strongest association signal (Table 3 and addi-
tional file 1 - Supplemental Table E2). Compared with the
rs10192393 T/T homozygotes, individuals with C/C or C/
T genotype had a 1.90 times higher risk of BHR (nominal
P = 0.0059) and a 2.03 times higher risk of BHR asthma
(nominal P = 0.0067) (Table 3). Among the five SNPs,
rs1430090, rs6737251 and rs7580359 were in a haplo-
type block defined by the solid LD spine (Figure 1) [23].
We further explored the associations with haplotypes con-
structed by the two SNPs outside the block and by the
three SNPs inside the block, respectively. As shown in
Table 4, compared to subjects with the TC haplotype con-
structed by rs10192393 and rs1430092, ones with the CC
haplotype had a 1.99 times higher risk of BHR (nominal
P = 0.0040) and a 2.15 times higher risk of BHR asthma
(nominal P = 0.0041). No significant association was
found for haplotypes inside the block. Compared to the
study-wide significance level of 0.0041, only the haplo-
type associations remained significant.
HLA-G  In single-SNP analyses, compared with the
rs1736935 C/C homozygotes, individuals with T/T geno-
type had a lower risk of BHR asthma (OR = 0.64, nominal
P = 0.044) (Table 3). Under the additive genetic model,
we estimated that each additional copy of the T allele
reduced the risk of BHR asthma by 19% (OR = 0.81; nom-
inal P = 0.043). In haplotype analyses, we found that com-
pared to the AT haplotype constructed by rs1632949 and
rs1736935, each additional copy of the AC haplotype had
a 1.40 times higher risk of BHR asthma (nominal P =
0.0086) (Table 4). However, compared to the study-wide
significance level of 0.0041, all the associations became
not significant.
Table 1: Basic phenotypic information of 1183 population-based samples.
Asthmatic Samples Non-asthmatic Samples
Variables N Mean SD N Mean SD
Age (yr)* 543 28.5 16.1 640 31.0 16.7
Gender (male%) 543 53.2 - 640 49.2 -
Height (m)* 543 1.50 0.16 639 1.54 0.14
Weight (kg)* 543 44.4 13.6 639 48.6 12.8
BMI (kg/m2) a* 543 19.0 3.19 639 20.1 3.15
Smoke (yes%) 543 25.8 - 640 25.8 -
Education (elementary school or lower%) 367 42.8 - 492 43.7 -
Occupation (farmer%) 365 69.0 - 493 65.7 -
Dust/gas/fume Exposure (yes%) 366 11.7 - 492 10.8 -
Asthma (yes%)* 543 100 - 640 0 -
FEV1 (L)b* 526 2.20 0.84 623 2.81 0.89
FVC (L)c* 526 3.22 1.14 623 3.51 1.09
% Predicted FEV1* 526 83.2 18.9 623 94.0 10.0
% Predicted FVC 526 92.3 11.9 623 93.5 9.1
BHR (yes%) d* 432 87.3 - 546 24.0 -
Total Log IgE (IU)* 320 6.11 1.40 296 2.89 1.77
Positive Skin Reactions (yes%)e* 427 81.0 - 590 32.2 -
a: Body mass index.
b: Forced expiratory volume in 1s.
c: Forced vital capacity.
d: Bronchial hyperresponsiveness.
e: Mean wheel size for the total 10 applied antigens.
* P < 0.05 between two groups.
Table 2: Minor allele frequencies of the 9 studied SNPs.
Gene SNP Allele MAFa
PHF11 rs2247119 T->C 0.422
rs1046295 G->A 0.496
DPP10 rs10192393 T->C 0.054
rs1430092 C->T 0.089
rs1430090 T->G 0.395
rs6737251 C->T 0.255
rs7580359 C->T 0.268
HLA-G rs1632949 A->G 0.308
rs1736935 C->T 0.415
a: Minor allele frequency (MAF) was calculated from 640 non-
asthmatic samples.BMC Medical Genetics 2009, 10:123 http://www.biomedcentral.com/1471-2350/10/123
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Discussion
Because asthma is a clinical syndrome and there are no
clinical benchmarks, several asthma-related phenotypes
are used to help the diagnosis. Since these phenotypes are
objective, quantitative, and of less genetic heterogeneity,
they are often used in genetic studies to search for the
causal genetic variants for asthma [26]. Evidence has
shown that combining asthma-related phenotypes with
physician's diagnosis of asthma led to a stronger associa-
tion to the asthma candidate genes, which may shed light
on the different molecular pathways underlying asthma
[4,22]. In our current study, we selected study samples by
combining asthma affectation status and three asthma-
related phenotypes, including total serum IgE levels,
bronchial responsiveness test, and skin prick test. This
study design provided more power to examine various
mechanisms of asthma. We observed that combining BHR
with asthma produced stronger genetic effects (odds
ratios) in both DPP10 single SNP and haplotype analyses
as compared to BHR alone. This indicates that the gene
may participate in asthma susceptibility through the
mechanisms of BHR.
Our results confirm previous associations of DPP10 and
asthma or asthma-related phenotype, but differ in the
details. In the positional cloning study of DPP10, Allen et
al. demonstrated that the strongest association signal to
asthma came from the allele 3 of a microsatellite marker
D2S308 in a population containing three Caucasian
cohorts [2]. Studies have shown that DPP10 is strongly
expressed in central neural system and is a modulator of
voltage-gated K+ channel inactivation [2,11]. This indi-
cates that DPP10 may be important in neural regulation
of airway smooth muscle and control of airway reactivity,
Table 3: Associations between SNPs in PHF11, DPP10, HLA-G and asthma or asthma-related phenotypes, adjusted for age, gender, 
height, weight, BMI and smoking status.
Gene Phenotype SNP Genotype Negative
N (%)
Positive
N (%)
OR (95% CI) Nominal
P Value
PHF11 SPTa rs2247119 TT 167 (35.9) 161 (30.8) 1
CT 213 (45.8) 263 (50.3) 1.27 (0.95-1.67) 0.10
CC 85 (18.3) 99 (18.9) 1.14 (0.79-1.65) 0.48
Dominant Model 1.23 (0.94-1.61) 0.13
SPT + Asthma b rs2247119 TT 138 (35.8) 109 (32.2) 1
CT 179 (46.5) 169 (49.9) 1.18 (0.84-1.65) 0.35
CC 68 (17.7) 61 (18.0) 1.08 (0.69-1.67) 0.74
Dominant Model 1.15 (0.84-1.58) 0.39
DPP10 MTCH Challengec rs10192393 TT 404 (92.0) 393 (86.2) 1
CT 34 (7.7) 62 (13.6) 1.91 (1.21-3.03) 0.0059
CC 1 (0.2) 1 (0.2) 1.46 (0.09-23.56) 0.79
Dominant Model 1.90 (1.20-3.00) 0.0059
MTCH Challenge + Asthma d rs10192393 TT 360 (92.3) 284 (85.8) 1
CT 29 (7.4) 46 (13.9) 2.04 (1.22-3.42) 0.0070
CC 1 (0.3) 1 (0.3) 1.66 (0.10-27.13) 0.72
Dominant Model 2.03 (1.22-3.37) 0.0067
HLA-G MTCH Challenge rs1736935 CC 150 (32.6) 191 (37.5) 1
CT 227 (49.3) 241 (47.3) 0.82 (0.61-1.09) 0.17
TT 83 (18.0) 77 (15.1) 0.73 (0.49-1.07) 0.10
Additive Model 0.85 (0.70-1.02) 0.079
MTCH Challenge + Asthma rs1736935 CC 136 (33.9) 152 (39.3) 1
CT 192 (47.9) 181 (46.8) 0.84 (0.61-1.15) 0.27
TT 73 (18.2) 54 (14.0) 0.64 (0.41-0.99) 0.044
Additive Model 0.81 (0.65-0.99) 0.043
a: Skin prick test. A positive skin prick test was defined as at least one antigen-induced wheal size >2 mm of the saline control value.
b: Combined asthma status and skin prick test. All cases were asthmatic with a positive skin test result, while all controls were non-asthmatic with 
a negative skin test result.
c: Airway methacholine challenge test. Negative and positive responses were defined as no PD20 observed and a PD20 observed in the test, 
respectively.
d: Combined asthma status and methacholine challenge test. All cases were asthmatic with a positive challenge test result, while all controls were 
non-asthmatic with a negative challenge test result.BMC Medical Genetics 2009, 10:123 http://www.biomedcentral.com/1471-2350/10/123
Page 6 of 9
(page number not for citation purposes)
which may explain our finding that the haplotype con-
taining the SNP rs10192393 in DPP10, 4 kb upstream of
D2S308, was associated with BHR and BHR asthma. For
PHF11 and HLA-G, the associations with asthma or
asthma-related phenotypes were only significant at the
nominal level, and became not significant after the adjust-
ment for multiple testing. However, these results might
still be of interest. Zhang et al. identified the locus at the
PHF11 gene as a determinant of serum IgE levels [1].
However, we did not find any association between PHF11
Table 4: Associations between haplotypes in PFH11, DPP10, HLA-G and asthma-related phenotypes, adjusted for age, gender, height, 
weight, BMI and smoking status.
Gene Phenotype Haplotypea Negative Positive OR (95% CI)b Nominal
P value
Frequency (%) Frequency (%)
rs2247119 rs1046295
PHF11 SPTc T G 47.9 46.5 1
C A 38.9 39.7 1.06 (0.81-1.40) 0.67
T A 11.3 9.6 0.85 (0.60-1.19) 0.34
C G 2.0 4.1 2.05 (1.11-3.81) 0.023
SPT + Asthma d T G 48.4 47.7 1
C A 38.5 39.0 1.04 (0.75-1.44) 0.80
T A 10.9 9.6 0.88 (0.59-1.32) 0.55
C G 2.1 3.7 1.59 (0.78-3.25) 0.20
rs10192393 rs1430092
DPP10 MTCH Challengee T C 88.2 84.4 1
T T 7.9 8.7 1.25 (0.86-1.82) 0.24
C C 3.9 6.8 1.99 (1.25-3.17) 0.0040*
MTCH Challenge + Asthma 
r
T C 88.1 83.2 1
T T 8.1 9.8 1.33 (0.88-2.01) 0.17
C C 3.8 7.0 2.15 (1.28-3.62) 0.0041*
rs1430090 rs6737251 rs7580359
MTCH Challenge G C C 38.7 39.2 1
T C C 34.6 35.5 0.98 (0.74-1.31) 0.90
T T T 25.3 23.6 0.88 (0.66-1.16) 0.36
G C T 1.4 1.7 1.23 (0.54-2.78) 0.62
rs1632949 rs1736935
HLA-G MTCH Challenge A T 43.2 38.8 1
G C 31.5 32.1 1.15 (0.93-1.44) 0.20
A C 25.4 29.0 1.24 (0.99-1.56) 0.060
MTCH Challenge + Asthma A T 42.6 37.5 1
G C 32.2 30.8 1.11 (0.87-1.43) 0.40
A C 25.2 31.7 1.40 (1.09-1.80) 0.0086
a: Haplotypes with frequency ≥0.01 were considered.
b: The main effects of haplotypes were in dominant, dominant and additive models for PHF11, DPP10 and HLA-G, respectively.
c: Skin prick test. A positive skin prick test was defined as at least one antigen-induced wheal size >2 mm of the saline control value.
d: Combined asthma status and skin prick test. All cases were asthmatic with a positive skin test result, while all controls were non-asthmatic with 
a negative skin test result.
e: Airway methacholine challenge test. Negative and positive responses were defined as no PD20 observed and a PD20 observed in the test, 
respectively.
f: Combined asthma status and methacholine challenge test. All cases were asthmatic with a positive challenge test result, while all controls were 
non-asthmatic with a negative challenge test result.
*: The associations remained significant (adjusted P ≤ 0.05) after the adjustment for multiple testing.BMC Medical Genetics 2009, 10:123 http://www.biomedcentral.com/1471-2350/10/123
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and IgE in our Chinese cohort even at the nominal signif-
icance level. Recently, Jang et al. provided evidence for an
association between rs2247119 and rs1046295 in PHF11
and atopic dermatitis in a young Australian cohort [7]. In
their study, the T allele from rs2247119 and G allele from
rs1046295 were over-transmitted to children with atopic
dermatitis. The correlation between these two SNPs in
Chinese population (r2 = 0.53) is moderate compared
with that in Australian population (r2 = 0.92) [7]. In our
current study, however, we found that the haplotype con-
taining the C allele of rs2247119 (rather than the T allele)
and the G allele of rs1046295 was nominally associated
with an increased risk of positive skin reactions to anti-
gens. Nicolae et al. identified HLA-G as asthma and BHR
susceptibility gene in two Chicago cohorts by examining
pairwise combination of SNPs [3]. The association of SNP
rs1632947 in the promoter region of HLA-G with BHR
was confirmed in the Hutterite families, where the C allele
was over-transmitted to children with BHR. In our current
study, we found that the genotype containing the C allele
at rs1736935, one of the two selected tag SNPs 215 bp
upstream of rs1632947, and the haplotype containing the
rs1736935 C allele were nominally associated with an
increased risk of BHR asthma. It is probably due to the
small effect sizes of the genetic variants and lack of power
in the current study that the associations of PHF11 and
HLA-G with asthma or asthma-related phenotypes failed
to reach the study-wide significance level. Therefore, stud-
ies with larger sample sizes can be conducted to further
evaluate the nominal associations of PHF11 and HLA-G
identified in the current study.
The population-based study design is a common strategy
used in genetic studies of complex diseases. Population
homogeneity is desirable to avoid population stratifica-
tion. Our study samples are relatively homogenous. All of
them are from a rural area of Anqing, China, a region
known for a historically stable population. Not only is
there a predominant singular ethnic group, but there
exists a uniformity of occupation (farming) and lifestyle
throughout Anqing. This population homogeneity mini-
mizes the potential of population stratification that may
lead to false-positive associations. Also, in a previous
asthma candidate gene study, we tested 119 SNPs from
105 genes for associations with asthma using 170 asth-
matic cases and 347 controls selected from the same 3022
families where the current study subjects were sampled
[27]. We applied STRUCTURE2.1 to assess the presence of
population substructures within our previous study sam-
ples. A set of 111 SNPs after excluding potentially associ-
ated ones (p < 0.05 in association tests) was used in the
analyses. STRUCURE2.1 showed that a single substructure
had the highest likelihoods among all possible number of
substructures in the samples, which indicated that the
samples in our previous study were homogeneous. Even
though the study samples were different between the cur-
rent and previous studies, they were actually selected from
the same population pool in the same geographic region,
so the conclusion of no population stratification based on
one study can be generalized to the other study.
In the current study, several demographic factors, includ-
ing age, height, weight, and BMI, were slightly imbalanced
between asthmatic and non-asthmatic samples. To mini-
mize their potential confounding effects, we included
these factors as covariates in all the analyses. Furthermore,
we examined the distributions of these factors among
samples with different genotypes of studied SNPs and
found no significant differences. This indicated that there
were no correlations between studied SNPs and four
above-mentioned factors. Therefore, the results were not
confounded by age, height, weight, and BMI. Also, gender
did not bias the results since it was balanced between asth-
matic and non-asthmatic samples. Moreover, the genetic
effects were similar in gender-specific (males and females)
analyses and there was no significant interaction between
gender and the DPP10 haplotype in the log-likelihood-
ratio test (data not shown). Note that our study subjects
include both children and adults. Although evidence
LD structures of 5 SNPs on DPP10 Figure 1
LD structures of 5 SNPs on DPP10. D' values are listed 
in each cell and the haplotype block is defined by the solid 
spine of LD.BMC Medical Genetics 2009, 10:123 http://www.biomedcentral.com/1471-2350/10/123
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showed that childhood and adult asthma differed in sev-
eral parameters [28,29], the associations between PHF11,
DPP10, HLA-G and asthma or asthma-related phenotypes
were found in both groups [1-3,7]. Therefore, these genes
may play roles in the common pathway of childhood and
adult asthma. Further subgroup (subjects aged <21 yrs
and ≥21 yrs) analyses were performed and similar associ-
ations were detected in both younger and older groups;
also, there was no significant interaction between age and
the DPP10 haplotype by the log-likelihood-ratio test
(data not shown). This suggests that age may have a min-
imal effect on the associations.
Conclusion
In conclusion, our study was the first one to demonstrate
that DPP10 is associated with BHR and BHR asthma in a
Chinese population. Our study provides supportive evi-
dence to the previously reported associations between the
DPP10 gene and asthma or asthma-related phenotypes in
Caucasian populations.
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